Alector Inc (ALEC) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Alector Inc has achieved a revenue compound annual growth rate (CAGR) of 47.8%, while earnings have grown at -11.1% CAGR.
Historical revenue and profitability trends for Alector Inc
The chart above illustrates Alector Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Alector Inc's business.
How efficiently Alector Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Alector Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Alector Inc to continue growing earnings in the coming year. The consensus analyst rating is 3.8889 based on 9 analysts.
Based on our comprehensive analysis, Alector Inc (ALEC) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Alector Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Alector Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ALEC Valuation, ALEC Dividend, ALEC Financial Health
Compare: ALEC vs AAPL, ALEC vs MSFT, ALEC vs GOOGL